Πέμπτη 13 Απριλίου 2017

Pembrolizumab and indoximod for melanoma

Prof Zakharia speaks with ecancer at AACR 2017 about adding indoximod, an IDO inhibitor, to pembrolizumab to treat advanced melanoma. In this interim report of results from 102 patients, he highlights that 52% of all patients respond, and that those...

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2o9z4hu
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Δημοφιλείς αναρτήσεις